Nigil Haroon
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
FOXO3a Polymorphisms Are Not Associated With Axial Spondyloarthritis or Psoriatic Arthritis Susceptibility in a Canadian Cohort, With Ancestry-Specific Findings.
Journal: International journal of rheumatic diseases
Published: May 01, 2026
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1.
Journal: The Journal of rheumatology
Published: April 01, 2026
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1.
Journal: The Journal of rheumatology
Published: April 01, 2026
Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy.
Journal: ACR open rheumatology
Published: February 07, 2026
Segmental spinal damage predicts mobility restriction and functional decline in radiographic axial spondyloarthritis: a longitudinal study.
Journal: Rheumatology (Oxford, England)
Published: December 23, 2025
Determinants of Difficult-to-Manage and Treatment-Refractory Axial Spondyloarthritis: A Cross-Sectional Analysis within a Longitudinal Cohort.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 09, 2025
Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non-Biologic Treatment: Results From an Overlap Weighting Analysis in High-Risk Patients With Axial Spondyloarthritis.
Journal: International journal of rheumatic diseases
Published: October 29, 2025
T cells, the next big target in axSpA?
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 06, 2025
Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility.
Journal: Research square
Published: July 25, 2025
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).
Journal: Musculoskeletal care
Published: October 22, 2024
Prologue: Spondyloarthritis Unmet Research Needs Conference IV.
Journal: The Journal of rheumatology
Published: September 11, 2024
Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis.
Journal: Annals of the rheumatic diseases
Published: August 14, 2024
Last Updated: 09/26/2026